Beneficient Unveils Strategy to Challenge Former CEO-Linked Debt and Equity Claims

Beneficient has laid out a strategy to remove a cluster of debt, equity and contractual claims tied to former chief executive Brad Heppner, with the Dallas-based alternative-assets company first seeking a negotiated resolution and preparing to litigate if those talks fail.

The proposal centers on about $130 million of contested debt asserted by HCLP Nominees, L.L.C., equity interests linked to Heppner and his affiliates, and roughly $88 million of other amounts Beneficient says are purportedly owed under remaining agreements. Beneficient also wants to exchange Heppner-linked preferred equity with an aggregate liquidation preference of about $850 million for 162,132 shares of its Class A common stock.

Beneficient said in a September 23 SEC-filed release that the proposed resolution would eliminate substantially all of its debt, end Heppner’s ownership of its Class B common stock and remove associated super-voting, board-appointment and consent rights. The company stressed that no definitive agreement has been signed and that there is no assurance a consensual resolution will be reached.

What Beneficient wants to unwind

The HCLP piece is the most direct balance-sheet issue. Beneficient’s June 30 quarterly filing showed about $94.3 million of debt outstanding under the HCLP loan arrangements and $32.2 million of unpaid accrued interest. No principal or interest payments had been made on the first- and second-lien agreements since an interest payment in March 2023. The September 23 release rounded the contested principal and accrued interest to approximately $130 million.

Those loans had been treated as related-party debt in Beneficient’s filings. The company’s June quarter report said the HCLP loan purportedly matured on April 14, 2025, and that HCLP sent a notice on July 30, 2025 asserting events of default. Beneficient has since disputed the validity of the obligations and the liens securing them. The latest proposal seeks to eliminate the HCLP claim rather than refinance or repay it.

A separate part of the plan concerns Heppner-linked equity. Beneficient says preferred equity in one of its subsidiaries carries an aggregate liquidation preference of roughly $850 million. Under the contemplated settlement, those interests and other Heppner-linked equity would be converted and exchanged for an aggregate 162,132 shares of Beneficient Class A common stock. The $850 million figure is the stated liquidation preference of the preferred interests, not a statement by Beneficient that the interests currently have that market value.

The company also wants all remaining contractual arrangements with Heppner or his affiliated entities terminated or voided. Beneficient puts the amounts purportedly owed under those arrangements or otherwise at about $88 million and says the proposed resolution would extinguish them without payment. In return, Beneficient would provide customary releases to Heppner and his affiliated entities.

Taken together, the proposed steps would do more than remove a disputed creditor claim. They would also simplify ownership and governance rights that Beneficient has repeatedly identified in its public filings as connected to its former chief executive and related entities. The company says removing those interests would reduce a potential dilution overhang and separate Heppner from the business.

Heppner’s conviction reshaped the HCLP dispute

The legal backdrop changed sharply in May. A federal jury convicted Heppner of securities fraud, wire fraud, conspiracy to commit securities fraud and wire fraud, and making false statements to auditors after a three-week trial in the Southern District of New York. The case concerned a scheme involving GWG Holdings, where Heppner had served as chairman.

According to the Justice Department’s case record, the prosecution established that Heppner used HCLP in a scheme to extract funds from GWG. DOJ said at the time of conviction that Heppner fabricated a $141 million debt that Beneficient, then a GWG subsidiary he had founded, purportedly owed to HCLP. Prosecutors also said HCLP was controlled by Heppner and that funds transferred through the structure ultimately reached his personal accounts.

Beneficient now cites the conviction and the trial record as support for its position that the HCLP debt currently asserted against it is invalid and unenforceable. That position is stronger than a simple commercial disagreement over repayment terms, but the September 23 announcement does not itself resolve the remaining civil claims. Beneficient still needs either a binding agreement with Heppner and the relevant entities or relief through litigation if an agreement cannot be reached.

The distinction matters because the criminal verdict and Beneficient’s proposed balance-sheet cleanup are related but not identical issues. The jury verdict established Heppner’s criminal liability in the GWG fraud case. Beneficient’s effort to eliminate the present HCLP debt, preferred equity and other contractual claims is the company’s next step, and some of the relief it seeks may depend on further agreements, court action, third-party cooperation or government processes.

Earlier filings show how the dispute had already begun to affect Beneficient before the criminal trial ended. HCLP asserted defaults in 2025 and sought remedies tied to the loan collateral. Beneficient, for its part, said it was evaluating the validity of the HCLP obligations and considering claims against Heppner, HCLP and parties that it believed controlled HCLP. The September strategy turns that earlier defensive posture into a more specific proposal for eliminating the disputed relationships.

October 21 is the company’s negotiating deadline

Beneficient says it is actively pursuing a consensual resolution with Heppner and wants to complete one before his sentencing. The Justice Department’s case page says sentencing has been rescheduled to October 21, 2026, at 4 p.m. in federal court in New York.

If a settlement is reached on the terms Beneficient outlined, the company says the result would remove substantially all of its debt, end Heppner’s Class B ownership and related governance rights, and settle the preferred-equity issue through the Class A share exchange. Beneficient also says the arrangement is intended to assist Heppner in making restitution to other victims of his criminal conduct.

Failure to reach a deal would send the matter down a different path. Beneficient says it is prepared to pursue available claims and remedies against Heppner, HCLP, other affiliated entities and individuals who received proceeds derived from his conduct. Litigation would introduce its own uncertainty over timing, recoveries, legal costs and the treatment of the disputed obligations while those proceedings continue.

The company itself lists additional risks around the strategy, including the possibility that it cannot obtain the relief it wants, disputes over the validity or value of the HCLP and equity claims, required third-party or governmental actions, and accounting or tax consequences. Those cautions limit how much of the proposed balance-sheet change can be treated as accomplished today.

The next concrete marker is therefore not an accounting adjustment but either a signed resolution or a move into litigation. Beneficient has tied its preferred timetable to the October 21 sentencing date, giving investors a specific window in which to watch for another filing that shows whether the company has converted its strategy into a binding outcome.